How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Tattoo Numbing Cream Market
- By Product Type: Lidocaine-based Creams, Benzocaine-based Creams, Prilocaine-based Creams, Combination Formulations (e.g., Lidocaine and Prilocaine)
- By Formulation: Creams, Gels, Sprays, Ointments
- By Application Method: Topical Application, Spray Application
- By End User: Professional Tattoo Studios, Individual Consumers, Medical Clinics
- By Distribution Channel: Online Retail, Pharmacies and Drugstores, Specialty Beauty and Tattoo Supply Stores, Direct Sales
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Lidocaine-based Creams leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 287 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.172 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.180 →
Full report · locked preview
Everything inside the Tattoo Numbing Cream Market report
A complete, evidence-based study - 12 chapters and 120 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 4
Formulation 4
Application Method 2
End User 3
Distribution Channel 4
Companies profiled
Dr. Numb
Hush Anesthetic Tattoo Numbing Gel
Numb Master
Uber Numb
Numbify
Numb Skin Care
Numb 520
Numbify Tattoo Numbing Cream
Zensa Numbing Cream
Numb Pro
Numbify Plus
Tattoo Goo
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Dr. Numb
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Hush Anesthetic Tattoo Numbing Gel
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Numb Master
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Uber Numb
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Numbify
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Numb Skin Care
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Numb 520
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Numbify Tattoo Numbing Cream
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Zensa Numbing Cream
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Numb Pro
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Numbify Plus
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Tattoo Goo
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Numb 911
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Numbify Ultra
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Numbify Max
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$641.7M by 2033 · 3.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Lidocaine-based Creams62.0
- Benzocaine-based Creams9.6
- Prilocaine-based Creams18.5
- Combination Formulations (e.g., Lidocaine and Prilocaine)9.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$163.2M → $224.9M · 4.1%
Europe$113.7M → $149.0M · 3.4%
Asia Pacific$103.8M → $140.6M · 3.9%
Latin America$64.3M → $79.6M · 2.7%
Middle East and Africa$49.4M → $69.0M · 4.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →3.272026
3.272027
3.292028
3.312029
3.322030
3.322031
3.342032
3.352033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Dr. Numb10.8
- Hush Anesthetic Tattoo Numbing Gel23.2
- Numb Master5.7
- Uber Numb14.8
- Numbify12.5
- Numb Skin Care5.1
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type33.6%
Formulation20.8%
Application Method20.1%
End User14.2%
Distribution Channel11.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.9
- Europe22.5
- Asia Pacific21.2
- Latin America12.0
- Middle East and Africa10.4
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Dr. Numb | 78 | 94 | 90 | 81 | 87 | 79 | 85 |
| Hush Anesthetic Tattoo Numbing Gel | 79 | 74 | 84 | 74 | 74 | 80 | 78 |
| Numb Master | 66 | 77 | 68 | 84 | 85 | 79 | 77 |
| Uber Numb | 74 | 62 | 67 | 58 | 76 | 63 | 67 |
| Numbify | 57 | 64 | 53 | 60 | 52 | 72 | 60 |
| Numb Skin Care | 62 | 53 | 67 | 65 | 48 | 65 | 60 |
| Numb 520 | 44 | 61 | 44 | 54 | 46 | 59 | 51 |
| Numbify Tattoo Numbing Cream | 48 | 52 | 46 | 37 | 57 | 37 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Dr. Numb
- Hush Anesthetic Tattoo Numbing Gel
- Numb Master
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Dr. Numb | ✓ | ✓ | ✓ | ✓ | ◐ | ✓ |
| Hush Anesthetic Tattoo Numbing Gel | ◐ | ◐ | ✓ | ◐ | ◐ | ◐ |
| Numb Master | ◐ | ◐ | − | ✓ | ◐ | ◐ |
| Uber Numb | ✓ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Numbify | ◐ | ◐ | − | ◐ | − | − |
| Numb Skin Care | − | ◐ | ✓ | − | ◐ | ◐ |
| Numb 520 | − | − | − | ◐ | − | − |
| Numbify Tattoo Numbing Cream | ◐ | ◐ | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Dr. Numb85
2Hush Anesthetic Tattoo Numbing Gel78
3Numb Master77
4Uber Numb67
5Numbify60
6Numb Skin Care60
7Numb 52051
8Numbify Tattoo Numbing Cream46
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Dr. NumbHush Anesthetic Tattoo Numbing Gel
Challenger2
Strong scale, closing on the leaders.
Numb MasterUber Numb
Contender2
Focused players with pockets of strength.
NumbifyNumb Skin Care
Niche2
Specialists in a single segment or region.
Numb 520Numbify Tattoo Numbing Cream
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Tattoo Numbing Cream Market — a $39M beachhead inside a $700M market.
Beachhead (SOM)$39Mobtainable near-term
Serviceable (SAM)$261Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Lidocaine-based Creams
Best fit — highest urgency & budget in Product Type.
Economic buyer80 fit
Benzocaine-based Creams
Strong fit — clear ROI and a fast path to value.
End user69 fit
Prilocaine-based Creams
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Formulation & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application Method
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel30%
Digital / self-serve19%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Tattoo Numbing Cream Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified38%
Sales qualified21%
Evaluation12%
Closed-won7%
$18.4KCAC
$71KLTV
3.8:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Tattoo Numbing Cream Market is a high-growth opportunity — $945M by 2033, compounding at 10.5%.
TAM · 2025$424Mtoday
TAM · 2033$945Mforecast
CAGR10.5%2027–2033
Cumulative$5.89Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$945MTotal addressable market
SAM$361MServiceable available market
SOM$65MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.5% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$945MLarge & growingTAM by 2033 at 10.5% CAGR
$361MServiceable nowreachable with today’s model
$65MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$737MBear6.8% CAGR
$945MBase10.5% CAGR
$1.21BBull13.9% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Formulation optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Tattoo Numbing Cream Market — a $5.46B market by 2033. Plan: grow share from 10.2% to 17.1%.
Market size · 2033$5.46Btotal addressable
Market CAGR6.8%2027–2033
Target share17.1%from 10.2% today
Revenue ambition$934Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.2% | 17.1% | On track |
| Revenue | $548M | $934M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 37.8% | 40.9% | Ahead |
| Customer retention | 91.8% | 96.0% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Formulation capability
A defensible second engine — invest in Formulation to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Formulation
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $124M capacity & capability investment
- Greenlight bolt-on M&A in Formulation
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAt risk
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Tattoo Numbing Cream Market conversation — a $6.59B market you can size, segment and defend in minutes.
Market size · 2033$6.59Btotal opportunity
Growth4.8%CAGR to 2033
Addressable buyers1,461+accounts in scope
Typical ROI7.1×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.1×return on cost, year one
< 4 mopayback period
$75K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Dr. NumbHush Anesthetic Tattoo Numbing GelNumb MasterUber NumbNumbifyNumb Skin CareNumb 520Numbify Tattoo Numbing Cream+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Tattoo Numbing Cream Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Tattoo Numbing Cream Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Tattoo Cleaning Machine Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportTaste Masking Excipient Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportTartaric Acid Pharmaceutical Excipients Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportTartar Emetic Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportTarsometatarsal Arthrodesis Treatment Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportTargeting Small Molecule Tumor Drugs Market
Market size, share, segmentation and regional forecast.
$437M market · 2025 base year
View reportTargeting p53 Cancer Therapies Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportTargeting DNA Repair Drugs Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportTarget Humanized Mice Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportTargeted Therapy for Breast Cancer Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportTargeted Therapy for Brain Cancer Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportTargeted Therapy for Bladder Cancer Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.